Orphan designation: 2-(2-Chlorobenzylidene)hydrazinecarboximidamide acetate Treatment of Charcot-Marie-Tooth disease, 14/12/2015 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 21 August 2026 - 14:00

Orphan designation: 2-(2-Chlorobenzylidene)hydrazinecarboximidamide acetate Treatment of Charcot-Marie-Tooth disease, 14/12/2015 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-15-1598

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters